Sandborn, W. J., Feagan, B. G., Radford-Smith, G., Kovacs, A., Enns, R., Innes, A., & Patel, J. (2004). CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn’s disease: A randomised, double blind, placebo controlled trial. Copyright 2004 by Gut.

Sandborn, W J., B G. Feagan, G. Radford-Smith, A. Kovacs, R. Enns, A. Innes, e J. Patel. CDP571, a Humanised Monoclonal Antibody to Tumour Necrosis Factor α, for Moderate to Severe Crohn’s Disease: A Randomised, Double Blind, Placebo Controlled Trial. Copyright 2004 by Gut, 2004.

Sandborn, W J., et al. CDP571, a Humanised Monoclonal Antibody to Tumour Necrosis Factor α, for Moderate to Severe Crohn’s Disease: A Randomised, Double Blind, Placebo Controlled Trial. Copyright 2004 by Gut, 2004.